Preclinical research at BYU may lead to development of low-cost immunotherapy
Researchers at BYU are investigating a new immunotechnology called MOTO-CAR, which can genetically engineer immune cells that penetrate solid tumors and attacks the tumor cells.
1 Nov 20:35 · KSL.com